EligibleTrials

Type 2 Diabetes and Blood Brain Barrier Improvement

Recruiting · NCT06322212 · Interventional (participants receive a specific treatment) · Lead sponsor: University of California, Los Angeles

View the official record on ClinicalTrials.gov →
Type 2 diabetes

Interventions studied

PlaceboThiamine

What this trial is about

The majority of T2DM adults show thiamine (vitamin B1) deficiency which may contribute to impaired function. This study will examine patients with T2DM through brain MRI scans, cognition assessments, blood tests, and questionnaires. Our goal is to see if a thiamine treatment (taking vitamin B1 capsules) can improve function. Patients will be asked to come to UCLA two times three months apart and each visit will last about 2.5-3 hours.

Who can take part

Age range
40 Years to 65 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Early Phase 1
Study type
Interventional (participants receive a specific treatment)

Inclusion criteria

Exclusion criteria

Where it is running

1 location listed across 1 US state.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.